Diplomat Pharmacy, Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Consent Letter Agreement with Dan Davison (Filed With SEC on December 9, 2019)
- Consent Letter Agreement with Brian Griffin (Filed With SEC on December 9, 2019)
- Form of Omnibus Amendment to Award Agreement (Filed With SEC on November 12, 2019)
- Offer letter dated May 9, 2018 by and between Brian Griffin and the Company (Filed With SEC on August 7, 2018)
- Sixth Amendment to Prime Vendor Agreement, effective October 24, 2017, by and among AmerisourceBergen Drug Corporation and each Company subsidiary named therein (Filed With SEC on March 1, 2018)
- Commitment Letter by and among Diplomat Pharmacy, Inc., JPMorgan Chase Bank, N.A., and Capital One, National Association dated November 15, 2017 (Filed With SEC on November 16, 2017)
- Fifth Amendment to Prime Vendor Agreement, effective August 3, 2017, by and among AmerisourceBergen Drug Corporation and the Company subsidiaries named therein (Filed With SEC on November 6, 2017)
- Fourth Amendment to Prime Vendor Agreement, effective May 8, 2017, by and among AmerisourceBergen Drug Corporation and the Company subsidiaries named therein (Filed With SEC on November 6, 2017)
- THIRD AMENDMENT TO PRIME VENDOR AGREEMENT (Filed With SEC on October 6, 2016)
- General Electric Capital Corporation 2 Bethesda Metro Center Suite 600 Bethesda, MD 20814-5318 (Filed With SEC on February 29, 2016)
- SECOND AMENDMENT TO PRIME VENDOR AGREEMENT (Filed With SEC on September 15, 2015)
- First Amendment to Prime Vendor Agreement (Filed With SEC on August 19, 2014)
- PRIME VENDOR AGREEMENT (Filed With SEC on August 19, 2014)
